ScoreWhy is Chongqing Zhifei Biological Products Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -11.88% and Operating profit at -231.00% over the last 5 years
2
With a fall in Net Sales of -4.06%, the company declared Very Negative results in Mar 26
- The company has declared negative results for the last 10 consecutive quarters
- NET SALES(HY) At CNY 3,481.21 MM has Grown at -38.24%
- NET PROFIT(HY) At CNY -13,898.61 MM has Grown at -3,002.15%
- INTEREST(HY) At CNY 173.01 MM has Grown at 29.9%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -38.66%, its profits have fallen by -5869.5%
- At the current price, the company has a high dividend yield of 0
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -38.66% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Chongqing Zhifei Biological Products Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Chongqing Zhifei Biological Products Co., Ltd.
-38.68%
-1.45
41.55%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-11.88%
EBIT Growth (5y)
-231.00%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
4.21
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
0.73
Tax Ratio
15.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.53%
ROE (avg)
30.14%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.76
EV to EBIT
-2.13
EV to EBITDA
-2.18
EV to Capital Employed
1.47
EV to Sales
4.21
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-69.12%
ROE (Latest)
-95.93%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
PRE-TAX PROFIT(Q)
At CNY -539.9 MM has Grown at 87.72%
NET PROFIT(Q)
At CNY -420.19 MM has Grown at 88.63%
-26What is not working for the Company
NET PROFIT(HY)
At CNY -808.51 MM has Grown at -32.82%
INTEREST(HY)
At CNY 164.21 MM has Grown at 6.73%
ROCE(HY)
Lowest at -65.95%
NET SALES(Q)
At CNY 1,873.58 MM has Fallen at -14.49%
RAW MATERIAL COST(Y)
Grown by 86.45% (YoY
CASH AND EQV(HY)
Lowest at CNY 3,814.12 MM
Here's what is working for Chongqing Zhifei Biological Products Co., Ltd.
Pre-Tax Profit
At CNY -539.9 MM has Grown at 87.72%
over average net sales of the previous four periods of CNY -4,395.75 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -420.19 MM has Grown at 88.63%
over average net sales of the previous four periods of CNY -3,695.38 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Here's what is not working for Chongqing Zhifei Biological Products Co., Ltd.
Net Sales
At CNY 1,873.58 MM has Fallen at -14.49%
over average net sales of the previous four periods of CNY 2,191.09 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Interest
At CNY 164.21 MM has Grown at 6.73%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Cash and Eqv
Lowest at CNY 3,814.12 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 86.45% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
